Angiogenic Proteins
Cysteine-Rich Protein 61
Angiogenesis Inducing Agents
Vascular Endothelial Growth Factor A
Neovascularization, Physiologic
Neovascularization, Pathologic
Vascular Endothelial Growth Factor Receptor-1
Vascular Endothelial Growth Factors
Endothelial Growth Factors
Endothelial Cells
Lymphokines
Fibroblast Growth Factor 2
Angiogenesis Inhibitors
Endothelium, Vascular
Vascular Endothelial Growth Factor Receptor-2
Angiopoietin-1
Angiopoietin-2
Recombinant adenovirus expressing wild-type p53 is antiangiogenic: a proposed mechanism for bystander effect. (1/368)
Angiogenesis is required for the growth and progression of malignancies. Recent studies have demonstrated that genetic alterations may accompany acquisition of the angiogenic phenotype. The tumor suppressor gene p53 is most frequently mutated in human cancers and is also known to be a transcriptional regulator of a variety of genes. Here, we investigated the antiangiogenic effect of the wild-type p53 (wt-p53) gene transfer on a human non-small cell lung cancer cell line. Mutant p53-expressing H226Br non-small cell lung cancer cells were transduced with the wt-p53 gene using a recombinant adenoviral vector (Ad5CMVp53) and applied to semiquantitative reverse transcription-PCRs for the detection of altered mRNA expression of angiogenic and/or antiangiogenic factors. In vivo neovascularization assay of Ad5CMVp53-infected cells was then performed using a membrane-diffusion chamber system s.c. transplanted in nu/nu mice. We also evaluated the effect of Ad5CMVp53-infected H226Br cells on nontransduced tumor cells in vivo by s.c. inoculating mixture of cells into nu/nu mice. Ad5CMVp53 infection markedly inhibited the expression of an angiogenic factor, vascular endothelial growth factor, and increased the expression of a novel antiangiogenic factor, brain-specific angiogenesis inhibitor 1, resulting in reduced neovascularization in vivo. Mixing experiments showed that tumor cells transduced with the wt-p53 gene inhibited the in vivo tumor growth of adjacent nontransduced cells. Our data suggest that a recombinant adenovirus expressing the wt-p53 gene is antiangiogenic, which may explain, in part, the mechanism of the bystander effect induced by the wt-p53 gene transfer on adjacent tumor cells. (+info)Inhibition of angiogenesis and tumour growth by VEGF121-toxin conjugate: differential effect on proliferating endothelial cells. (2/368)
Vascular endothelial growth factor (VEGF) plays an important role in tumour angiogenesis. VEGF binds to tyrosine kinase receptors, which are expressed almost exclusively on tumour endothelium. Therefore, VEGF can be used to target toxin molecules to tumour vessels for anti-angiogenic therapy. However, recent evidence suggests that VEGF can also bind in an isoform-specific fashion to a newly identified neuropilin-1 (NP-1) receptor. NP-1 is widely expressed in normal tissue and presents a potential target for unwanted toxicity. As a consequence, we investigated whether the VEGF121 isoform, which lacks the NP-1 binding domain, could be used to target toxin polypeptides to tumour vasculature. Treatment of endothelial cells with a VEGF121-diphtheria toxin (DT385) conjugate selectively inhibited proliferating endothelial cells, whereas confluent cultures were completely resistant to the construct. In addition, VEGF121-DT385 conjugate treatment completely prevented tumour cell induced angiogenesis in vivo. Most importantly, the conjugate inhibited tumour growth in athymic mice and induced tumour-specific vascular damage. There was also no apparent toxicity associated with the treatment. Our results suggest that proliferating endothelial cells are highly sensitive to VEGF121-toxin conjugates and that the binding to NP-1 receptors is not necessary for efficient inhibition of tumour growth. (+info)Significant correlation between interleukin 10 expression and vascularization through angiopoietin/TIE2 networks in non-small cell lung cancer. (3/368)
The expression of interleukin 10 (IL-10) is correlated with clinical prognosis in non-small cell lung cancer [NSCLC (H. Hatanaka et al., ANN: ONCOL:, 11: 815--819, 2000)]. However, the effects of IL-10 expression on vascularization in NSCLC are not apparent. We examined the gene expression of IL-10/IL-10 receptor and various angiogenic/angioinhibitory factors in 95 NSCLC samples to determine the correlation between IL-10 production and vascularization. Vascular endothelial growth factor, angiopoietin [Ang (Ang-1 and Ang-2)], thrombospondin, brain-specific angiogenesis inhibitor 1, vascular endothelial growth factor receptors (KDR and flt-1), and Ang receptor (TIE2) gene expression were evaluated by reverse transcription-PCR. The cellular localization of these factors and vascularity in the cancer stroma were examined immunohistochemically. Seventy-eight (82.1%) and 93 (97.9%) of these 95 NSCLCs were positive for IL-10 and IL-10 receptor, respectively. Ang-1, Ang-2, and TIE2 gene expression was seen in 76 (97.4%), 73 (93.6%), and 78 (100%) of 78 IL-10-positive NSCLCs, respectively, and was significantly correlated with IL-10 gene expression (P < 0.0088, <0.0008, and 0.0305, respectively; Fisher's exact method). The localizations of Ang-1, Ang-2, and TIE2 were confirmed within tumor cells immunohistochemically. Vascular number and measurement area were significantly higher in the IL-10-positive NSCLCs (33.500 +/- 9.299/microm(2) and 4.742 +/- 1.287%) as compared with IL-10-negative NSCLCs (10.611 +/- 2.839/microm(2) and 0.718 +/- 0.331%; Mann-Whitney U test, P = 0.0039). The IL-10 expression did not show any significant correlation with the expression of other factors. These results suggested that tumor-produced IL-10 promotes stromal vascularization through expression of Ang-1, Ang-2, and TIE2. (+info)Overexpression of the p53-inducible brain-specific angiogenesis inhibitor 1 suppresses efficiently tumour angiogenesis. (4/368)
The brain-specific angiogenesis inhibitor 1 gene has been isolated in an attempt to find fragments with p53 "functional" binding sites. As reported herein and by others, brain-specific angiogenesis inhibitor 1 expression is present in some normal tissues, but is reduced or lost in tumour tissues. Such data and its particular structure prompted the hypothesis that brain-specific angiogenesis inhibitor 1 may act as a mediator in the local angiogenesis balance. We herein demonstrate that brain-specific angiogenesis inhibitor 1 over-expression suppresses tumour angiogenesis, delaying significantly the human tumour growth in immunodeficient mice. The inhibitory effect of brain-specific angiogenesis inhibitor 1 was documented using our intravital microscopy system, strongly implicating brain-specific angiogenesis inhibitor 1 as a mediator in the control of tumour angiogenesis. In contrast, in vitro tumour cell proliferation was not inhibited by brain-specific angiogenesis inhibitor 1 transfection, whereas some level of cytotoxicity was assessed for endothelial cells. Immunohistochemical analysis of tumour samples confirmed a reduction in the microvessel density index in brain-specific angiogenesis inhibitor 1-overexpressing tumours. At messenger level, moderate changes could be detected, involving the down-regulation of vascular endothelial growth factor and collagenase-1 expression. Furthermore, brain-specific angiogenesis inhibitor 1 expression that was lost in a selection of human cancer cell lines could be restored by wild-type p53 adenoviral transfection. Brain-specific angiogenesis inhibitor 1 should be considered for gene therapy and development of efficient drugs based on endogenous antiangiogenic molecules. (+info)Selectivity and promiscuity of the first and second PDZ domains of PSD-95 and synapse-associated protein 102. (5/368)
PDZ domains typically interact with the very carboxyl terminus of their binding partners. Type 1 PDZ domains usually require valine, leucine, or isoleucine at the very COOH-terminal (P(0)) position, and serine or threonine 2 residues upstream at P(-2). We quantitatively defined the contributions of carboxyl-terminal residues to binding selectivity of the prototypic interactions of the PDZ domains of postsynaptic density protein 95 (PSD-95) and its homolog synapse-associated protein 90 (SAP102) with the NR2b subunit of the N-methyl-d-aspartate-type glutamate receptor. Our studies indicate that all of the last five residues of NR2b contribute to the binding selectivity. Prominent were a requirement for glutamate or glutamine at P(-3) and for valine at P(0) for high affinity binding and a preference for threonine over serine at P(-2), in the context of the last 11 residues of the NR2b COOH terminus. This analysis predicts a COOH-terminal (E/Q)(S/T)XV consensus sequence for the strongest binding to the first two PDZ domains of PSD-95 and SAP102. A search of the human genome sequences for proteins with a COOH-terminal (E/Q)(S/T)XV motif yielded 50 proteins, many of which have not been previously identified as PSD-95 or SAP102 binding partners. Two of these proteins, brain-specific angiogenesis inhibitor 1 and protein kinase Calpha, co-immunoprecipitated with PSD-95 and SAP102 from rat brain extracts. (+info)Brain angiogenesis inhibitor 1 is differentially expressed in normal brain and glioblastoma independently of p53 expression. (6/368)
Brain angiogenesis inhibitors (BAI) are putative transmembrane proteins containing an extracellular domain with thrombospondin type-1 repeats which can exhibit anti-angiogenic activity. BAI1 mRNA is expressed mainly in the brain, while BAI2 and BAI3 mRNAs are more widely expressed. We hypothesized that the BAI family might have anti-tumoral properties and studied the expression of BAI1 protein in normal human brain and in glioblastoma multiforme. We generated an anti-BAI1 antibody and showed that BAI1 was widely expressed in normal brain but was absent in 28 glioma cell lines and in the majority of human glioblastoma investigated. BAI1 expression did not correlate with TP53 status and we did not confirm previous findings that p53 regulates BAI1 mRNA expression in glioma cells. The finding that expression of BAI proteins may be lost during tumor formation is of special interest as restoration of their function in tumors may be of therapeutic benefit. (+info)Vascular endothelial growth factor principally acts as the main angiogenic factor in the early stage of human osteoblastogenesis. (7/368)
Vascular endothelial growth factor (VEGF)-mediated angiogenesis is essential for bone formation. However, the effect of VEGF on osteoblastic cells during osteoblastogenesis is still controversial. The aim of this study was to clarify the relationship between osteoblastic cells derived from human mesenchymal stem cells (MSCs) and VEGF in the early stage of osteoblastic differentiation. Continuous dexamethasone treatment with a low concentration stimulated osteoblastogenesis of MSCs and the expression of VEGF121 mRNA. The VEGF secretion from osteoblastic cells also increased along with osteoblastogenesis. Neuropilin-1, which mainly binds VEGF165, was detected at all stages during early osteoblastogenesis, but VEGF receptor-1 and -2 were not detected on RT-PCR analyses. In this study, VEGF had no direct effect on the proliferation of osteoblastic cells. However, the secreted VEGF in the conditioned medium of osteoblastic cells exhibited high angiogenic power as to endothelial cell proliferation. Our findings indicated that VEGF121 principally acts as the main angiogenic factor in the early stage of human osteoblastogenesis. The present study also demonstrated the differential expression of VEGF121 during osteoblastogenesis. The increase of VEGF in the early stage might be a useful marker of induction of bone formation due to human MSCs. (+info)Circulating proangiogenic cytokines and angiogenesis inhibitor endostatin in untreated patients with chronic lymphocytic leukemia. (8/368)
The serum concentration of two pro-angiogenic cytokines: basic fibroblast growth factor (bFGF) and transforming growth factor beta1 (TGF-beta1), and anti-angiogenic factor endostatin in the serum of 80 never treated B-cell chronic lymphocytic leukemia (CLL) patients and 27 healthy volunteers was measured using an enzyme linked immunosorbent assay. The serum levels of both bFGF and TGF-beta1 were found to be significantly higher in the CLL group (median 40.5 pg/ml and 38.6 ng/ml respectively) when compared to the control group (median 9.4 pg/ml and 18.9 ng/ml, respectively) (p<0.001). The levels of endostatin were not significantly different in CLL and control groups (median 12.3 ng/ml and 8.4 ng/ml, respectively) (p=0.09). In the group of CLL patients the level of bFGF was significantly higher in patients with progressive disease as compared with patients with stable disease (median 90.5 pg/ml and 40.5 pg/ml respectively) (p<0.001). Patients in Rai stage III and IV also had significantly higher levels of bFGF than patients in Rai stage 0-II (median 100.1 pg/ml and 29.3 pg/ml respectively) (p<0.001). The levels of both TGF-beta1 and endostatin were lower in patients in Rai stage III and IV (median 28.9 ng/ml and 9.1 ng/ml respectively) than in patients in Rai stage 0-II (42.8 ng/ml and 13.1 ng/ml respectively) (p<0.001 and p=0.002 respectively). The level of endostatin was also lower in the group of CLL patients with progressive disease (median 10.0 ng/ml) as compared to patients with stable disease (median 20.5 ng/ml) (p=0.008). In conclusion, the disturbance in the balance between pro- and anti-angiogenic factors may have an important influence on the course of CLL. (+info)Pathologic neovascularization can be seen in a variety of conditions, including cancer, diabetic retinopathy, and age-related macular degeneration. In cancer, for example, the formation of new blood vessels can help the tumor grow and spread to other parts of the body. In diabetic retinopathy, the growth of new blood vessels in the retina can cause vision loss and other complications.
There are several different types of pathologic neovascularization, including:
* Angiosarcoma: a type of cancer that arises from the cells lining blood vessels
* Hemangiomas: benign tumors that are composed of blood vessels
* Cavernous malformations: abnormal collections of blood vessels in the brain or other parts of the body
* Pyogenic granulomas: inflammatory lesions that can form in response to trauma or infection.
The diagnosis of pathologic neovascularization is typically made through a combination of physical examination, imaging studies (such as ultrasound, CT scans, or MRI), and biopsy. Treatment options vary depending on the underlying cause of the condition, but may include medications, surgery, or radiation therapy.
In summary, pathologic neovascularization is a process that occurs in response to injury or disease, and it can lead to serious complications. It is important for healthcare professionals to be aware of this condition and its various forms in order to provide appropriate diagnosis and treatment.
Vascular endothelial growth inhibitor
Benjamin P. Sachs
Syndecan 1
Syndecan-2
Angiopoietin-related protein 1
Syndecan-4
CXCL1
Syndecan-3
NOV (gene)
EGLN1
Stem-cell niche
Histidine-rich glycoprotein
TMEM155
Thrombospondin 1
Mitogen-activated protein kinase kinase kinase 6
Placental growth factor
Exosome (vesicle)
JMJD6
Diabetic retinopathy
Silmitasertib
Lee Byung-heon (biochemist)
Angiogenesis
Proteases in angiogenesis
HYAL1
Cystine knot
Junctional adhesion molecule
FGFBP1
Pre-eclampsia
PEDF
GBP1
Proto-oncogene tyrosine-protein kinase Src
Interferon
Postpartum psychosis
Philip Lazarovici
Mitogen
Tasquinimod
TSPAN7
Chromosome 6
Mir-126
Reverse transcription polymerase chain reaction
Glucose-6-phosphate isomerase
Kidney cancer
MicroRNA
Pegaptanib
Mir-221 microRNA
Proser2
Platelet-derived growth factor
Vascular endothelial growth factor C
Ofranergene obadenovec
Cathelicidin
Oncolytic virus
Cartilage-derived angiogenesis inhibitor
DGKA
Aminoacyl tRNA synthetase
ACTC1
PHF8
Subgranular zone
Molecular control of ovulation and luteinization in the primate follicle
Hypoxia-induced inhibin promotes tumor growth and vascular permeability in ovarian cancers | Communications Biology
ALSF Childhood Cancer Research Grants | Alex's Lemonade Stand Foundation for Childhood Cancer
Publication Detail
What's New for 2004 MeSH. NLM Technical Bulletin. 2003 Nov-Dec
Salzman, Lois 1998 - Office of NIH History and Stetten Museum
Biomarkers Search
Publikationen | Max-Planck-Institut für Polymerforschung
Erectile Dysfunction: Practice Essentials, Background, Anatomy
MeSH Browser
Lesions of Doom - How a Parasitic Bacterium Disrupts Blood Vessels in the Human Body
Oral Immunity & Infection Section: People | National Institute of Dental and Craniofacial Research
JCI -
Targeting hypoxia-inducible factors with 32-134D safely and effectively treats diabetic eye disease in mice
Technology to Improve Maternal Health: Workshop summary | National Institute of Biomedical Imaging and Bioengineering
Lixisenatide ameliorates cerebral ischemia-reperfusion injury via GLP-1 receptor dependent/independent pathways - PubMed
Alveolar capillary dysplasia with misalignment of pulmonary veins: MedlinePlus Genetics
Búsqueda | BVS CLAP/SMR-OPS/OMS
Zesergio Melo Jerez | IntechOpen
Transcript: Zeroing in on preeclampsia | NICHD - Eunice Kennedy Shriver National Institute of Child Health and Human Development
NIH Guide: RESEARCH ON ORAL WOUND HEALING AND TISSUE REGENERATION
Angiopoietin-2 | Colorado PROFILES
Scientists unravel the function of a sight-saving growth factor | National Eye Institute
WHO EMRO | Serum endostatin and vascular endothelial growth factor levels in patients with pre-eclampsia | Volume 12, issue 1...
WHO EMRO | Serum endostatin and vascular endothelial growth factor levels in patients with pre-eclampsia | Volume 12, issue 1...
High-tech delivery of common spice into tumors holds promise for cancer prevention|The Angiogenesis Foundation
DeCS
Protein Involved in Diabetic Eye Disease | National Institutes of Health (NIH)
MeSH Browser
Peptides5
- Amino Acids, Peptides and Proteins (D12): 246 new descriptors were added. (nih.gov)
- Intercellular signaling peptides and proteins that regulate the proliferation of new blood vessels under normal physiological conditions ( ANGIOGENESIS, PHYSIOLOGICAL ). (nih.gov)
- Researchers at the National Eye Institute (NEI) have determined how certain short protein fragments, called peptides, can protect neuronal cells found in the light-sensing retina layer at the back of the eye. (nih.gov)
- A team led by Patricia Becerra, Ph.D., chief of the NEI Section on Protein Structure and Function, had previously derived these peptides from a protein called pigment epithelium-derived factor (PEDF), which is produced by retinal pigment epithelial cells that line the back of the eye. (nih.gov)
- Further, the 44-mer and 17-mer peptides work by binding to a protein receptor (PEDF-R) on the surface of neurons. (nih.gov)
Angiogenesis10
- TGFβ family members, particularly BMP9 and TGFβ, are the most examined regulators of angiogenesis but have not been effective as targets for angiogenic therapy due to their pleiotropic functions in cancer and normal physiology 4 , 5 . (nature.com)
- 16. Biological Pathways Involved in Tumor Angiogenesis and Bevacizumab Based Anti-Angiogenic Therapy with Special References to Ovarian Cancer. (nih.gov)
- Through these experiments, the scientists determined that B. henselae can stimulate angiogenesis in human endothelial cells only if it possesses a functional copy of the gene that "codes for," or guides the synthesis of, the BafA protein. (scitechdaily.com)
- We believe that BafA proteins can be leveraged as tools for studying angiogenesis, and we also consider potential medical benefits," reports Prof Doi. (scitechdaily.com)
- Aberrant expression of angiogenic proteins during disease states such as tumorigenesis can also result in PATHOLOGICAL ANGIOGENESIS . (nih.gov)
- Patients may also receive drugs that inhibit vascular endothelial growth factor (VEGF), a protein that stimulates angiogenesis. (nih.gov)
- In fact, anti-VEGF therapy didn't affect the ability of aqueous fluid from patients to trigger angiogenesis, despite low levels of the protein. (nih.gov)
- Most importantly, inhibiting both VEGF and angiopoietin-like 4 reduced angiogenesis more than targeting just one of the proteins. (nih.gov)
- Mice that received the curcumin microparticles had significantly less tumor growth and a reduction in markers of tumor angiogenesis, including the development of microscopic tumor capillaries and expression of a key angiogenic protein, compared with mice that received a placebo. (angio.org)
- Oxygen tension and cytokines have been shown to influence trophoblast VEGF expression, suggesting that this particular family of angiogenic proteins plays an important role in placental angiogenesis [3]. (who.int)
VEGF11
- Finally, members of two classes of angiogenic factors, originally proposed as important for embryonic and pathologic (tumorigenic) vasculogenesis, appear induced in the granulosa layer of the preovulatory follicle, i.e., vascular endothelial growth factor (VEGF) and angiopoietin (ANGPT). (nih.gov)
- This is the very first report of a vascular endothelial growth factor (VEGF for short)-like protein produced by bacteria. (scitechdaily.com)
- We demonstrate that levels of angiogenic proteins regulated by hypoxia-inducible factor (HIF)-1 and -2 (HIFs) remain elevated in diabetic eyes despite treatment with anti-VEGF therapy. (jci.org)
- By restricting oxygen flow to retinal cells, the team went on to discover a protein called angiopoietin-like 4 that, like VEGF, is present at much higher levels in the oxygen-deprived cells. (nih.gov)
- The protein was also present at high levels in low-VEGF aqueous fluid from the eyes of patients who had recently received anti-VEGF therapy. (nih.gov)
- Meanwhile, the protein might prove useful for predicting which diabetic retinopathy patients will respond to anti-VEGF therapy. (nih.gov)
- Nous avons déterminé la concentration d'endostatine et de VEGF dans le sérum de 20 femmes non enceintes en bonne santé et de 64 femmes enceintes : 20 en bonne santé, 20 ayant une prééclampsie bénigne et 24 une prééclampsie grave. (who.int)
- We investigated the relationship of VEGF as an angiogenic growth factor and endostatin as an angiogenic inhibitor in patients with pre-eclampsia. (who.int)
- Additionally, PEDF is capable to inhibit the activity of angiogenic factors such as VEGF and FGF-2. (neuromics.com)
- Avastin exerts its anti-angiogenic activity by binding to soluble vascular endothelial growth factor (VEGF), a signaling protein that promotes the growth of new blood vessels. (sartorius.com)
- Expression of ChM-I decreased, while expression of VEGF and other pro-angiogenic factors increased, in OA cartilage. (jrheum.org)
Receptors3
- Receptors, G-Protein-Coupled was added as new class to the Cell Surface Receptors. (nih.gov)
- By binding to these receptors, BafA triggered the activation of a process inside the cells, involving proteins called mitogen-activated protein kinase (MAPK) and extracellular signal-regulated kinases (ERKs). (scitechdaily.com)
- Proteomic analysis of EV produced by EC in the proinflammatory conditions showed presence of several pro-inflammatory and immune proteins along with an enrichment in angiogenic receptors. (nih.gov)
Extracellular2
- During my postdoctoral work, I gained experience in molecular biology and biochemistry, specifically, studying the role of the extracellular matrix protein Fibulin-7 and its anti-angiogenic properties. (nih.gov)
- Our major research interests are in exploring the role of extracellular matrix components (soluble secreted proteins and extracellular vesicles) in cancer and intercellular communication. (edu.au)
Vascular4
- Targeting inhibin in vivo through knockdown and anti-inhibin strategies robustly reduces permeability in vivo and alters the balance of pro and anti-angiogenic mechanisms resulting in vascular normalization. (nature.com)
- Dr. Richard Levine - Preeclampsia is a disease of pregnancy usually occurring in first pregnancies and it is characterized by high blood pressure and generalized vascular leakiness, which results in considerable amounts of protein being spilled into the urine from the blood and also in protein and fluid penetrating the tissues. (nih.gov)
- OBJECTIVE: Chondromodulin-I (ChM-I), a cartilage derived anti-angiogenic factor, has been shown to regulate the vascular invasion during endochondral bone formation. (jrheum.org)
- Immunohistochemical studies showed that vascular invasion occurred in proximity to chondrocytes with high expression of pro-angiogenic markers, and decreased expression of ChM-I. CONCLUSION: High expression of ChM-I was detected in articular cartilage of growing and normal adult joints, implicating its role in the maintenance of avascularity of intact articular cartilage. (jrheum.org)
Lysate1
- Proteomics reveals differential adsorption of angiogenic platelet lysate proteins on calcium phosphate bone substitute materials. (mpg.de)
Expression8
- MAPKAP Kinase-2 Drives Expression of Angiogenic Factors by Tumor-Associated Macrophages in a Model of Inflammation-Induced Colon Cancer. (nih.gov)
- 4. Angiogenic protein expression in advanced epithelial ovarian cancer. (nih.gov)
- 7. Co-expression of angiogenic markers and associations with prognosis in advanced epithelial ovarian cancer: a Gynecologic Oncology Group study. (nih.gov)
- An increase in endothelial angiogenic ability, as well as overall increases in secreted VEGFA, ICAM1, and VCAM1 protein expression, was noted after epithelial exposure. (cdc.gov)
- Low IGFBP3 expression is associated with a high expression of angiogenic proteins related to HIF- 2? (rusthuisavondvrede.be)
- RT-PCR and immunoblot analyses confirmed that MALAT1 suppression reduced FGF2 expression, and Enzyme-Linked Immunosorbent Assays revealed that transfection with MALAT1 siRNAs reduced FGF2 protein secretion from neuroblastoma cells. (garvan.org.au)
- Expression of the cartilage derived anti-angiogenic factor chondromodulin-I decreases in the early stage of experimental osteoarthritis. (jrheum.org)
- RESULTS: Abundant expression of ChM-I protein was detected in avascular regions of the developing and adult healthy articular cartilage. (jrheum.org)
Microenvironment1
- Secretome can be defined as the total set of proteins released from normal and/or cancer cells into the surrounding microenvironment. (edu.au)
CCN11
- Targeted mutagenesis of the angiogenic protein CCN1 (CYR61). (bvsalud.org)
Inhibit1
- Previous studies on Bartonella henselae (B. henselae for short), the bacterium responsible for the cat-scratch disease, have shown that it can directly "inject" proteins that inhibit programmed cell death (apoptosis) into the endothelial cells. (scitechdaily.com)
Factors4
- This is a protein which is an Anti-angiogenic protein, meaning it is like a sponge and it sops up growth factors that are required for maintenance of the health of blood vessels. (nih.gov)
- So if there is enough of this anti-angiogenic protein, there won't be a sufficient supply of these growth factors getting to where they need to go and the woman will develop Preeclampsia. (nih.gov)
- Circulating angiogenic factors associated with response and survival in patients with acute graft-versus-host disease: results from Blood and Marrow Transplant Clinical Trials Network 0302 and 0802. (ucdenver.edu)
- Angiogenic growth factors correlate with disease severity in young patients with autosomal dominant polycystic kidney disease. (ucdenver.edu)
Endothelial2
- They also observed that exposing human endothelial cells to the isolated BafA protein caused the cells to multiply. (scitechdaily.com)
- A key component of the anti-angiogenic action of PEDF is the induction of apoptosis in proliferating endothelial cells. (neuromics.com)
Tumor1
- Hypoxia, a driver of tumor growth and metastasis, regulates angiogenic pathways that are targets for vessel normalization and ovarian cancer management. (nature.com)
Enzymes2
- Proteins and Enzymes: A total of 65 new enzyme classes have been added to the category of Enzymes. (nih.gov)
- Several new major enzyme categories include: DNA Repair Enzymes, Metalloexopeptidases, Oxidoreductases Acting on CH-CH Group Donors, Proprotein Convertases, and Ubiquitin-Protein Ligase Complexes. (nih.gov)
Regulate1
- Mutations in the FOXF1 gene that cause ACD/MPV result in an inactive protein that cannot regulate development, leading to abnormal formation of the pulmonary blood vessels and gastrointestinal tract. (medlineplus.gov)
Ovarian cancer2
Prognosis1
- Anti-Angiogenic (Metronomic) Chemotherapy in Children with Poor Prognosis. (alexslemonade.org)
Selective1
- Endosomal sorting results in a selective separation of the protein corona from nanoparticles. (mpg.de)
PEDF5
- PEDF protein (center) has two domains with different functions. (nih.gov)
- The PEDF protein has functionally distinct domains. (nih.gov)
- Without the presence of proteins and other cells in their usual retinal environment, immature photoreceptors quickly die but can be preserved with PEDF. (nih.gov)
- Becerra and colleagues found that PEDF stimulates amacrine cells to develop neurites in their cell culture model and that the 44-mer and 17-mer were at least as effective - or better - at stimulating these connections than the native protein. (nih.gov)
- PEDF is a noninhibitory serpin with neurotrophic, anti-angiogenic, and anti-tumorigenic properties. (neuromics.com)
Kinase1
- MAPK-activated protein kinase 2 (MK2), a major effector of the p38 MAPK stress and DNA damage response signaling pathway, and a critical regulator of pro-inflammatory cytokine production, has been identified as a key contributor to colon tumorigenesis under conditions of chronic inflammation. (nih.gov)
Factor3
- They have also named this protein as Bartonella angiogenic factor A, or "BafA" for short. (scitechdaily.com)
- The protein produced from the FOXF1 gene is a transcription factor, which means that it attaches (binds) to specific regions of DNA and helps control the activity of many other genes. (medlineplus.gov)
- Angiopoietin-like 4 is a potent angiogenic factor and a novel therapeutic target for patients with proliferative diabetic retinopathy. (nih.gov)
Disease4
- Dr. Richard Levine - Basically in this article we described the characteristics of a second protein that we have discovered, maybe related to Preeclampsia and in this article we more or less demonstrate that it is important in causing what we believe is the cause of this disease. (nih.gov)
- So the implications are if you could reduce even the level of one of these proteins, you could probably roll back the disease or prevent the disease from happening. (nih.gov)
- We also think that since these proteins are elevated two to three months before the onset of the disease, high levels can be used as a marker to indicate that a woman is susceptible to developing the disease and may get the disease later on in the pregnancy. (nih.gov)
- Researchers identified a protein involved in an advanced stage of diabetic retinopathy, a diabetic eye disease that threatens vision. (nih.gov)
Gene1
- Deletion of one copy of the FOXF1 gene in each cell reduces the production of the FOXF1 protein. (medlineplus.gov)
Scientists1
- The scientists also speculate that BafA proteins could be used in regenerative medicine, which is a highly specialized branch of medicine that deals with replacing or regenerating lost or damaged parts of the body. (scitechdaily.com)
Mutations1
- Moreover, we generated the iCMFs with hiPSC-CMs with mutations in myosin-binding protein C (MYBPC3) to have a proof-of-concept of iCMFs in modeling cardiac hypertrophic phenotype. (stanford.edu)
Properties2
Cells2
Important1
- The FOXF1 protein is important in development of the lungs and their blood vessels. (medlineplus.gov)
Levels1
- The way to distinguish Preeclampsia from these other conditions would undoubtedly be to take a blood sample and find the high levels of one or both of these proteins. (nih.gov)
Development2
- The FOXF1 protein is also involved in the development of the gastrointestinal tract. (medlineplus.gov)
- A shortage of FOXF1 protein affects the development of pulmonary blood vessels and causes the main features of ACD/MPV. (medlineplus.gov)
Effects1
- Importantly, addition of recombinant FGF2 protein to the cell culture media reversed the effects of MALAT1 siRNA on vasculature formation. (garvan.org.au)
Human2
- It is estimated that about 10-15% of the proteins encoded by the human genome can be secreted by the well characterised classical secretory pathway. (edu.au)
- In particular, the present invention relates to angiogenic extracts obtained from deer antler velvet, and compositions containing said extracts for use in the treatment of wounds, injuries and diseases in human and animal medical practice. (patentsencyclopedia.com)
Components1
- These two broad categories bring together the protein components that are part of biological respiration and photosynthesis. (nih.gov)
Formation1
- Antibacterial Nanostructured Surfaces Modulate Protein Adsorption, Inflammatory Responses, and Fibrous Capsule Formation. (mpg.de)
Type1
- Dr. Richard Levine - Well this is the second protein of this type that we have found, and we believe that most of the types of Preeclampsia are caused by these two proteins. (nih.gov)